from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0056/rplI

LFCtreatmentdescriptionclass of inhibitor

1.079

Amikacinug/mL Amikacintranslation

1.553

Cap5-10ug/mL Capreomycintranslation

2.197

Rox10-50 ug/mL Roxithromycintranslation

0.559

SM2-5 ug/mL Streptomycintranslation

2.271

Tet5-10 ug/mL Tetracyclinetranslation

0.066

Rif0.2-5ug/mL Rifampicintranscription

0.375

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.667

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.387

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.477

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.539

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.264

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.487

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.245

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.141

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.240

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.460

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.839

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.652

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.215

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.586

KCN5-20 ug/mL Potassium cyaniderespiration

-0.905

NaN30.2-2 mM Sodium aziderespiration

0.794

Nigericin50 uM Nigericinrespiration

0.308

TRC10-150 ug/mL Triclosanrespiration

-0.782

TRZ10-25 ug/mL Thioridazinerespiration

-0.734

Valinomycin0.5-10 uM Valinomycinrespiration

0.499

ZnSO42 mM ZnSO4respiration

-0.317

menadione6-10 ug/mL Menadionerespiration

-0.308

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.576

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.471

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.345

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.249

NRP_1Non-replicating persistence stage 1dosRassociated

0.261

Amp0.2mg/mL AmpicillincellWall

0.472

Cephalexin20-100 ug/mL CephalexincellWall

0.606

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.152

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.028

EMB10-20 ug/mL EthambutolcellWall

0.254

Eta12-40 ug/mL EthionamidecellWall

0.378

INH0.2-0.4 ug/mL IsoniazidcellWall

0.098

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.112

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.052

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.350

BZA0.12 mg/mL BenzamidearomaticAmides

0.354

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.013

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.741

H2O24 mM hydrogen peroxideDNAdamaging

1.415

Levo10 ug/mL LevofloxacinDNAdamaging

1.211

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.281

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.232

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.849

UVUV-irradiationDNAdamaging

-0.559

ARP41-4 ug/mL Antitubercular compound ARP4?

0.421

Antimycin12.5-50 ug/mL Antimycin A?

0.089

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.341

PA_110-50 ug/mL Antitubercular compound PA-1?

0.415

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.886

PA8240.2-2 ug/mL PA-824?

-1.610

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.170

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.098

Verapamil50 uM Verapamil?

-0.216

mercaptoethanol2 mM 2-Mercaptoethanol?

0.198

methoxatin10-20 ug/mL Methoxatin?